17/08/2026
A study by Hatoon A. Niyazi and colleagues (King Abdulaziz University) evaluates the antifungal and anti-inflammatory potential of 2,3-dichloro-6-(trifluoromethoxy) quinoxaline against clinically relevant fungal pathogens. The findings demonstrate notable fungicidal activity against Candida glabrata and Candida krusei, efficacy against C. albicans in an oral candidiasis model, and dose-dependent suppression of key inflammatory markers, highlighting its potential as a dual-action candidate for further therapeutic development.
Read the full article here 👉 https://bit.ly/3TZR3M0
Keywords: ,